FdaApplication
ANDA 209564
Identifiers
- fda_app_no: ANDA209564
Properties
| Property | Value |
|---|---|
| applicant_name | MYLAN PHARMACEUTICALS INC |
| application_type | ANDA |
| approval_date | 2021-02-09 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| LINACLOTIDE | LINACLOTIDE | 290MCG | CAPSULE;ORAL |
| LINACLOTIDE | LINACLOTIDE | 145MCG | CAPSULE;ORAL |
2 products